| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |